Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematologic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02900716
What this trial is testing

Safety Study of BTK Inhibitor, DTRMWXHS-12, Used Singly or in Combination, in CLL and B-cell Lymphomas

Who this might be right for
Chronic Lymphocytic LeukemiaB-Cell Lymphoma
Zhejiang DTRM Biopharma 48
Not applicableEnded earlyNCT02114606
What this trial is testing

Diagnosis and Monitoring of Eosinophilic Esophagitis Using the Cytosponge

Who this might be right for
Eosinophilic EsophagitisEoE
University of North Carolina, Chapel Hill 86
Not applicableLooking for participantsNCT07093606
What this trial is testing

Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura

Who this might be right for
ITP - Immune Thrombocytopenia
Sohag University 100
Not applicableStudy completedNCT05212233
What this trial is testing

Financial Difficulty in Patients With Blood Cancer

Who this might be right for
Chronic Lymphocytic LeukemiaMultiple Myeloma
UNC Lineberger Comprehensive Cancer Center 218
Testing effectiveness (Phase 2)Study completedNCT06865352
What this trial is testing

Safety and Preliminary Efficacy of Donor-derived Anti-leukemia Cytotoxic T Lymphocytes for the Prevention of Leukemia Relapse in Children Given Haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Lymphoblastic Leukemia ALLAcute Myeloid Leukemia (AML)
Fondazione IRCCS Policlinico San Matteo di Pavia 15
Early research (Phase 1)Study completedNCT03301207
What this trial is testing

Evaluate the Effect of Ibrutinib on the Pharmacokinetics of Oral Contraceptives, CYP2B6, and CYP3A4 Substrates in Female Participants With B Cell Malignancy

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Janssen Research & Development, LLC 25
Not applicableLooking for participantsNCT06773871
What this trial is testing

Feasibility and Safety of Exercise in Patients With Low-risk Myeloid Cancers and Precursor Conditions

Who this might be right for
Myelodysplastic SyndromeCytopenia
Rigshospitalet, Denmark 36
Testing effectiveness (Phase 2)Study completedNCT03469934
What this trial is testing

Proof of Concept Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Severe Eosinophilic Asthma

Who this might be right for
Eosinophilic Asthma
AnaptysBio, Inc. 25
Testing effectiveness (Phase 2)Study completedNCT02963493
What this trial is testing

Melphalan Flufenamide (Melflufen) Plus Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Oncopeptides AB 157
Testing effectiveness (Phase 2)Ended earlyNCT01542684
What this trial is testing

Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 8
Not applicableUnknownNCT05326984
What this trial is testing

Effect of Metformin on ABCB1 and AMPK Expression in Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Hospital General de Mexico 20
Not applicableLooking for participantsNCT07514052
What this trial is testing

Predicting Response to Selinexor-Based Therapy in Relapsed/Refractory Multiple Myeloma: A Multicenter Prospective Study

Who this might be right for
Multiple Myeloma of Bone
Shanxi Bethune Hospital 127
Large-scale testing (Phase 3)Ended earlyNCT01376700
What this trial is testing

Early Prophylaxis Immunologic Challenge (EPIC) Study

Who this might be right for
Hemophilia A
Baxalta now part of Shire 22
Early research (Phase 1)Ended earlyNCT00234000
What this trial is testing

Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Jonsson Comprehensive Cancer Center 1
Not applicableUnknownNCT01889407
What this trial is testing

Idarubicin Overcomes MDR1 Induced Chemoresistance With Higher Induction Remission Rate and Quality Than Daunorubicin in Acute Myeloid Leukemia Patients

Who this might be right for
Acute Myeloid Leukemia
Nanfang Hospital, Southern Medical University 94
Testing effectiveness (Phase 2)Ended earlyNCT02685111
What this trial is testing

Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)

Who this might be right for
Breast CancerNeutropeniaFebrile Neutropenia
Asan Medical Center 22
Large-scale testing (Phase 3)Study completedNCT01734044
What this trial is testing

RhTPO Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of ITP

Who this might be right for
PurpuraIdiopathic Thrombocytopenic Purpura
Shandong University 158
Large-scale testing (Phase 3)Study completedNCT00469144
What this trial is testing

IV Busulfan With Allo-BMT: Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic SyndromeLeukemiaAcute Myeloid Leukemia
M.D. Anderson Cancer Center 233
Early research (Phase 1)Study completedNCT03892044
What this trial is testing

Duvelisib and Nivolumab in Treating Patients With Richter Syndrome or Transformed Follicular Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaRecurrent Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma+5 more
David Bond, MD 7
Not applicableLooking for participantsNCT06928909
What this trial is testing

Leukemia Adapted Protocol

Who this might be right for
Acute Myeloid Leukaemia
Baylor College of Medicine 30
Next Page